Recall: Accupril Tablets

May 2022Pharmacy Updates
Pfizer is recalling batches of Accupril tablets (Quinapril HCl – 10 mg, 20 mg, and 40 mg) due to the presence of a nitrosamine, Nnitrosoquinapril, that was observed in recent testing at levels above the Acceptable Daily Intake (ADI) level. Read the full text of the Accupril Tablets recall.

Recent Announcements

Medicaid provider update: High-cost Medicaid drug billing

Billing requirements for Medicaid-covered drugs
Dec. 2025Important Notices

CME Webinar: The State of Telehealth in 2026

Please join us for a live, CME-accredited webinar on Tuesday, Jan. 27, from noon to 1 p.m. that will share updates on the state of telehealth for 2026.
Dec. 2025Education/Webinars

Formulary updates effective Jan. 1, 2026

Review upcoming policy and operational updates
Dec. 2025Pharmacy Updates